UCSF Benioff Children's Hospitals are harnessing next-generation genomic technology to develop individualized drug cocktails in a new trial for children with a type of malignant brain tumor. This precision-medicine approach ...
Aug 30, 2018
0
8
Glioma is the most common type of primary malignant brain tumor in the United States; glioblastoma being the most common type of glioma in adults. While sex differences in the incidence and survival rates of glioma were known, ...
Jun 28, 2018
0
17
Zika virus, known for causing microcephaly in babies by attacking the cells that give rise to the fetus's cerebral cortex, could be an alternative for treatment of glioblastoma, the most common and aggressive malignant brain ...
Feb 22, 2018
0
58
(Medical Xpress)—It's not unusual for cancer patients being treated with chemotherapy to complain about not being able to think clearly, connect thoughts or concentrate on daily tasks. The complaint – often referred to ...
Feb 21, 2013
1
1
(Medical Xpress)—Scientists at Washington University School of Medicine in St. Louis have identified a biological marker that may help predict survival in people with deadly brain tumors. The researchers showed that when ...
Oct 21, 2013
0
0
The experience of a fruit fly dying from cancer may seem worlds away from that of a human with a life-threatening tumor, yet University of California Berkeley researchers are finding commonalities between the two that could ...
Sep 16, 2021
0
31
Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center have discovered how different mutations in a specific gene help drive glioblastoma, the most lethal form of brain cancer.
Jul 11, 2018
0
3
More than two decades ago, Ryan Vincent had open brain surgery to remove a malignant brain tumor, resulting in a lengthy hospital stay and weeks of recovery at home. Recently, neurosurgeons at Houston Methodist Hospital removed ...
Nov 4, 2013
0
0
An enzyme that is responsible for the breakdown of specific amino acids in food plays a key role in the development of leukemias and brain cancer, according to scientists from the German Cancer Research Center (DKFZ) in Heidelberg. ...
Nov 9, 2017
0
43
The University of Delaware's Emily Day is a part of a team of researchers that has developed a nanotherapeutic capable of penetrating the blood-brain barrier.
Nov 25, 2013
0
0
